Skip to main content
Top
Published in: International Journal of Hematology 5/2014

01-05-2014 | Erratum

Erratum to: A prospective feasibility study of primary prophylaxis against invasive fungal disease with voriconazole following umbilical cord blood transplantation with fludarabine-based conditioning

Authors: Shinsuke Takagi, Hideki Araoka, Naoyuki Uchida, Yumiko Uchida, Daisuke Kaji, Hikari Ota, Aya Nishida, Kazuya Ishiwata, Masanori Tsuji, Hisashi Yamamoto, Tadaaki Ito, Naofumi Matsuno, Go Yamamoto, Yuki Asano-Mori, Masahiro Hayashi, Koji Izutsu, Kazuhiro Masuoka, Atsushi Wake, Shigeyoshi Makino, Akiko Yoneyama, Shuichi Taniguchi

Published in: International Journal of Hematology | Issue 5/2014

Login to get access

Excerpt

The authors would like to correct the error in the publication of the original article. The corrected detail is given below for your reading. …
Metadata
Title
Erratum to: A prospective feasibility study of primary prophylaxis against invasive fungal disease with voriconazole following umbilical cord blood transplantation with fludarabine-based conditioning
Authors
Shinsuke Takagi
Hideki Araoka
Naoyuki Uchida
Yumiko Uchida
Daisuke Kaji
Hikari Ota
Aya Nishida
Kazuya Ishiwata
Masanori Tsuji
Hisashi Yamamoto
Tadaaki Ito
Naofumi Matsuno
Go Yamamoto
Yuki Asano-Mori
Masahiro Hayashi
Koji Izutsu
Kazuhiro Masuoka
Atsushi Wake
Shigeyoshi Makino
Akiko Yoneyama
Shuichi Taniguchi
Publication date
01-05-2014
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 5/2014
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-014-1579-x

Other articles of this Issue 5/2014

International Journal of Hematology 5/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine